- Index
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10
- 11
- 12
- 13
- 14
- 15
- 16
- 17
- 18
- 19
- 20
- 21
- 22
- 23
- 24
- 25
- 26
- 27
- 28
- 29
- 30
- 31
- 32
- 33
- 34
- 35
Clariant has grouped its activities into four Business Areas (reportable segments): Care Chemicals (BU ICS), Catalysis (BU Catalysts), Natural Resources (BU Oil & Mining Services, BU Functional Minerals) and Plastics & Coatings (BU Additives, BU Masterbatches, BU Pigments). The Energy Storage business which pertained to the BA Catalysis was sold in 2015.
Intersegment transactions are entered into under the normal circumstances and terms and conditions that would also be available to unrelated third parties.
Segment assets consist of property, plant and equipment, goodwill, intangible assets, inventories, receivables and investments in associates. They exclude deferred tax assets, financial assets and operating cash. Segment liabilities comprise trade payables. They exclude items such as tax liabilities, provisions, pension liabilities and corporate borrowings. Capital expenditure comprises additions to property, plant and equipment and intangibles.
In the context of the rearrangement of its portfolio of business activities, Clariant disposed the Leather Services business as per 30 April 2014. For these reasons, up to the transaction closing date, this business was reported as discontinued operations in the financial report.
On 28 February 2015, Clariant sold its Energy Storage Activities pertaining to the Business Area Catalysis to the UK-based Johnson Matthey. Therefore, the related assets and liabilities are reported as held for sale at the end of 2014.
in CHF m |
Care Chemicals |
Catalysis |
Natural Resources |
Plastics & Coatings |
Total segments |
Corporate |
Total Group |
|||||||||||||||||||||||
|
2015 |
2014 |
2015 |
2014 |
2015 |
2014 |
2015 |
2014 |
2015 |
2014 |
2015 |
2014 |
2015 |
2014 |
||||||||||||||||
|
||||||||||||||||||||||||||||||
Segment sales |
1 446 |
1 514 |
704 |
729 |
1 219 |
1 300 |
2 458 |
2 599 |
5 827 |
6 142 |
|
– |
5 827 |
6 142 |
||||||||||||||||
Sales to other segments |
–1 |
–3 |
– |
|
–2 |
–3 |
–17 |
–20 |
–20 |
–26 |
|
– |
–20 |
–26 |
||||||||||||||||
Total sales |
1 445 |
1 511 |
704 |
729 |
1 217 |
1 297 |
2 441 |
2 579 |
5 807 |
6 116 |
– |
– |
5 807 |
6 116 |
||||||||||||||||
Operating expenses |
–1 225 |
–1 302 |
–565 |
–646 |
–1 044 |
–1 234 |
–2 230 |
–2 314 |
–5 064 |
–5 496 |
–247 |
–95 |
–5 311 |
–5 591 |
||||||||||||||||
Thereof: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||
Income from associates and joint ventures |
9 |
9 |
18 |
17 |
9 |
3 |
30 |
35 |
66 |
64 |
11 |
11 |
77 |
75 |
||||||||||||||||
Gain from disposals not qualifying as discontinued operations |
– |
|
12 |
|
3 |
5 |
– |
|
15 |
5 |
– |
163 |
15 |
168 |
||||||||||||||||
Restructuring, impairment and transaction-related costs |
–6 |
–2 |
– |
–30 |
–1 |
–96 |
–23 |
–10 |
–30 |
–138 |
–85 |
–90 |
–115 |
–228 |
||||||||||||||||
Operating income |
220 |
209 |
139 |
83 |
173 |
63 |
211 |
265 |
743 |
620 |
–247 |
–95 |
496 |
525 |
||||||||||||||||
Net financial expenses and taxes |
|
|
|
|
|
|
|
|
|
|
|
|
–269 |
–290 |
||||||||||||||||
Net result from continuing operations |
|
|
|
|
|
|
|
|
|
|
|
|
227 |
235 |
||||||||||||||||
Result from discontinued operations |
|
|
|
|
|
|
|
|
|
|
|
|
12 |
–18 |
||||||||||||||||
Net income |
|
|
|
|
|
|
|
|
|
|
|
|
239 |
217 |
||||||||||||||||
Segment assets |
982 |
1 014 |
1 631 |
1 627 |
872 |
997 |
1 700 |
1 889 |
5 185 |
5 527 |
|
|
5 185 |
5 527 |
||||||||||||||||
Segment liabilities |
–200 |
–224 |
–123 |
–107 |
–109 |
–135 |
–228 |
–226 |
–660 |
–692 |
|
|
–660 |
–692 |
||||||||||||||||
Net operating assets |
782 |
790 |
1 508 |
1 520 |
763 |
862 |
1 472 |
1 663 |
4 525 |
4 835 |
– |
– |
4 525 |
4 835 |
||||||||||||||||
Net assets held for sale |
– |
– |
– |
62 |
– |
– |
2 |
2 |
2 |
64 |
– |
–2 |
2 |
62 |
||||||||||||||||
Corporate assets without cash |
|
|
|
|
|
|
|
|
|
|
1 333 |
1 388 |
1 333 |
1 388 |
||||||||||||||||
Corporate liabilities without financial liabilities |
|
|
|
|
|
|
|
|
|
|
–2 054 |
–2 289 |
–2 054 |
–2 289 |
||||||||||||||||
Net debt2 |
|
|
|
|
|
|
|
|
|
|
–1 312 |
–1 263 |
–1 312 |
–1 263 |
||||||||||||||||
Total net assets |
782 |
790 |
1 508 |
1 582 |
763 |
862 |
1 474 |
1 665 |
4 527 |
4 899 |
–2 033 |
–2 166 |
2 494 |
2 733 |
||||||||||||||||
Thereof: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||
Investments in PPE and intangibles for the period |
97 |
90 |
148 |
49 |
33 |
38 |
78 |
79 |
356 |
256 |
45 |
65 |
401 |
321 |
||||||||||||||||
Investments in associates and joint ventures at the end of the period |
57 |
59 |
187 |
200 |
15 |
19 |
143 |
165 |
402 |
443 |
184 |
192 |
586 |
635 |
||||||||||||||||
Reconciliation of key figures |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||
Operating income |
220 |
209 |
139 |
83 |
173 |
63 |
211 |
265 |
743 |
620 |
–247 |
–95 |
496 |
525 |
||||||||||||||||
Add: systematic depreciation of PPE |
42 |
44 |
33 |
38 |
24 |
26 |
68 |
74 |
167 |
182 |
36 |
39 |
203 |
221 |
||||||||||||||||
Add: impairment |
– |
– |
– |
30 |
– |
87 |
13 |
– |
13 |
117 |
1 |
–1 |
14 |
116 |
||||||||||||||||
Add: amortization of intangible assets |
4 |
4 |
17 |
20 |
11 |
11 |
11 |
11 |
43 |
46 |
11 |
15 |
54 |
61 |
||||||||||||||||
EBITDA1 |
266 |
257 |
189 |
171 |
208 |
187 |
303 |
350 |
966 |
965 |
–199 |
–42 |
767 |
923 |
||||||||||||||||
Add: restructuring, impairment and transaction-related costs |
6 |
2 |
– |
30 |
1 |
96 |
23 |
10 |
30 |
138 |
85 |
90 |
115 |
228 |
||||||||||||||||
Less: impairment (reported under restructuring and impairment) |
– |
– |
– |
–30 |
– |
–87 |
–13 |
– |
–13 |
–117 |
–1 |
1 |
–14 |
–116 |
||||||||||||||||
Less: gain from disposals not qualifying as discontinued operations |
– |
– |
–12 |
– |
–3 |
–5 |
– |
– |
–15 |
–5 |
– |
–163 |
–15 |
–168 |
||||||||||||||||
EBITDA before exceptional items |
272 |
259 |
177 |
171 |
206 |
191 |
313 |
360 |
968 |
981 |
–115 |
–114 |
853 |
867 |
||||||||||||||||
Operating income |
220 |
209 |
139 |
83 |
173 |
63 |
211 |
265 |
743 |
620 |
–247 |
–95 |
496 |
525 |
||||||||||||||||
Add: restructuring, impairment and transaction-related costs |
6 |
2 |
– |
30 |
1 |
96 |
23 |
10 |
30 |
138 |
85 |
90 |
115 |
228 |
||||||||||||||||
Less: gain from disposals not qualifying as discontinued operations |
– |
– |
–12 |
– |
–3 |
–5 |
– |
– |
–15 |
–5 |
– |
–163 |
–15 |
–168 |
||||||||||||||||
Operating income before exceptional items |
226 |
211 |
127 |
113 |
171 |
154 |
234 |
275 |
758 |
753 |
-162 |
-168 |
596 |
585 |
in CHF m |
31.12.2015 |
31.12.2014 |
||
Non-current financial debt |
1 859 |
1 761 |
||
Add: current financial debt |
394 |
430 |
||
Less: cash and cash equivalents |
–789 |
–748 |
||
Less: Near-cash assets |
–152 |
–180 |
||
Net debt |
1 312 |
1 263 |
in CHF m |
31.12.2015 |
31.12.2014 |
||
Segment assets |
5 185 |
5 527 |
||
Segment assets reported as assets held for sale |
2 |
66 |
||
Corporate assets reported as assets held for sale |
– |
6 |
||
Corporate assets without cash |
1 333 |
1 388 |
||
Cash |
789 |
748 |
||
Near-cash assets |
152 |
180 |
||
Total Assets |
7 461 |
7 915 |
in CHF m |
Sales1 |
Non-current assets2 |
||||||||||
|
2015 |
2014 |
31.12.2015 |
31.12.2014 |
||||||||
|
||||||||||||
EMEA |
2 336 |
2 693 |
2 484 |
2 802 |
||||||||
of which Germany |
654 |
809 |
1 559 |
1 968 |
||||||||
of which Switzerland |
38 |
50 |
574 |
459 |
||||||||
of which MEA |
405 |
461 |
71 |
83 |
||||||||
North America |
1 077 |
1 006 |
893 |
805 |
||||||||
of which USA |
981 |
902 |
872 |
779 |
||||||||
Latin America |
1 021 |
984 |
224 |
268 |
||||||||
of which Brazil |
336 |
405 |
110 |
138 |
||||||||
Asia/Pacific |
1 373 |
1 433 |
495 |
395 |
||||||||
of which China |
450 |
519 |
217 |
182 |
||||||||
of which India |
159 |
141 |
63 |
62 |
||||||||
Total |
5 807 |
6 116 |
4 096 |
4 270 |
All of the Group’s segments generate their revenues to the largest extent from the sale of products. These come in such a great variety that a meaningful grouping below the segment information is not possible. The amounts reported for sales cover only continuing operations for both years.
For a description of the Business Units see note 1.23.
In 2013 Clariant adjusted its reporting segments and grouped its businesses with similar end-user markets and growth drivers. Today, the company reports in four distinct Business Areas: Care Chemicals, Catalysis, Natural Resources, and Plastics & Coatings. VIEW ENTIRE GLOSSARY
A substance that lowers the activation energy, thereby increasing the rate of a chemical reaction without being consumed by the reaction itself (Clariant Business Unit Catalysts). VIEW ENTIRE GLOSSARY
A substance added to products in small quantities to achieve certain properties or to improve a product (Clariant Business Unit Additives). VIEW ENTIRE GLOSSARY
These are plastic additives in the form of granules with dyestuffs or other additives used to dye or alter the properties of natural plastic. VIEW ENTIRE GLOSSARY
Pigments are substances used for coloring; they are used in a technical manner, for example in the manufacture of dyes, varnishes, and plastics. VIEW ENTIRE GLOSSARY